Agree, it’s time for this company to deliver. We get a tempting tweet from the CEO about waiting FDA Approval ( sounding like a biotech ) , and then later that day a tweet by some congressman supporting their story, and then finally on the same day an 8K filing having to do with re-pricing a public offering. It almost sounds like they needed to raise the price with the speculation tweet to enforce the 8K or something. An now, radio silence except for some unrelated noise. Not happy
News 
Market Data 
Discover 
